Cargando…
Suppression of Interferon-α Treatment Response by Host Negative Factors in Hepatitis B Virus Infection
Chronic hepatitis B virus (CHB) infection remains a major global public health issue for which there is still lacking effective curative treatment. Interferon-α (IFN-α) and its pegylated form have been approved as an anti-HBV drug with the advantage of antiviral activity and host immunity against HB...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8651562/ https://www.ncbi.nlm.nih.gov/pubmed/34901094 http://dx.doi.org/10.3389/fmed.2021.784172 |